2013, 12:450 http://www.malariajournal/content/12/1/Page 12 of32. Mwai L, Ochong E, Abdirahman A, Kiara SM, Ward S, Kokwaro G, Sasi P, Marsh K, Borrmann S, Mackinnon M, Nzila A: Chloroquine resistance before and after its withdrawal in Kenya. Malar J 2009, eight:106. 33. Gharbi M, Flegg JA, Hubert V, Kendjo E, Metcalf JE, Bertaux L, Guerin PJ, Le BJ, Aboubaca A, Agnamey P, Angoulvant A, Barbut P, Basset D, Belkadi G, Bellanger AP, Bemba D, Benoit-Vica F, Berry A, Bigel ML, Bonhomme J, Botterel F, Bouchaud O, Bougnoux ME, Bouree P, Bourgeois N, Branger C, Bret L, Buret B, Casalino E, Chevrier S, et al: Longitudinal study assessing the return of chloroquine susceptibility of Plasmodium falciparum in isolates from travellers returning from West and Central Africa, 2000011. Malar J 2013, 12:35. 34. Duah NO, Wilson MD, Ghansah A, Abuaku B, Edoh D, Quashie NB, Koram KA: Mutations in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance genes, and therapy outcomes in Ghanaian kids with uncomplicated malaria. J Trop Pediatr 2007, 53:271. 35. Djimde A, Doumbo OK, Cortese JF, Kayentao K, Doumbo S, Diourte Y, Coulibaly D, Dicko A, Su XZ, Nomura T, Fidock DA, Wellems TE, Plowe CV: A molecular marker for chloroquine-resistant falciparum malaria. N Engl JMed 2001, 344:25763. 36. Fidock DA, Nomura T, Talley AK, Cooper RA, Dzekunov SM, Ferdig MT, Ursos LM, Sidhu AB, NaudB, Deitsch KW, Su XZ, Wootton JC, Roepe PD, Wellems TE: Mutations inside the P. falciparum digestive vacuole transmembrane protein PFCRT and proof for their role in chloroquine resistance. Mol Cel 2000, six:86171. 37. Foote SJ, Kyle DE, Martin RK, Oduola AM, Forsyth K, Kemp DJ, Cowman AF: Quite a few alleles of your multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum. Nature 1990, 345:25558. 38. Duah NO, Matrevi SA, de Souza DK, Binnah DD, Tamakloe MM, Opoku VS, Onwona CO, Narh CA, Quashie NB, Abuaku B, Duplessis C, Kronmann KC, Koram KA: Enhanced pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance allelles in Ghanaian Plasmodium falciparum isolates right after the adjust of antimalarial drug therapy policy.ATX inhibitor 1 Malar J 2013, 12:377.NPB 39.PMID:24487575 Khalil IF, Alifrangis M, Tarimo DS, Staalso T, Satti GM, Theander TG, Ronn AM, Bygbjerg IC: The roles from the pfcrt 76 T and pfmdr1 86Y mutations, immunity and the initial level of parasitaemia, in predicting the outcome of chloroquine therapy in two areas with diverse transmission intensities. Ann Trop Med Parasitol 2005, 99:44148. 40. MOH: Anti-Malaria Drug Policy for Ghana. Accra, Ghana: Ministry of Well being; 2009. 41. Kwansa-Bentum B, Ayi I, Suzuki T, Otchere J, Kumagai T, Anyan WK, Asahi H, Akao N, Wilson MD, Boakye DA, Ohta N: Administrative practices of well being experts and use of artesunate-amodiaquine by neighborhood members for treating uncomplicated malaria in southern Ghana: implications for artemisinin-based mixture therapy deployment. Trop Med Int Well being 2011, 16:1215224. 42. United Nation Basic Assembly: Implementation of Common Assembly Resolution 66/289 on Consolidating Gains and Accelerating Efforts to Handle and Get rid of Malaria in Establishing Countries, Specifically in Africa, by 2015. 2012. United Nation document A/RES/66/289. 43. WHO: WHO Informal Consultation with Makers of Artemisinin-Based Pharmaceutical Solutions in use for the Treatment of Malaria. Geneva: World Well being Organization; 2007. 44. WHO: WHO briefing on Malaria Treatment Gu.